Literature DB >> 33357870

Biochemical characterization of Nostoc sp. exopolysaccharides and evaluation of potential use in wound healing.

Xavier Alvarez1, Andreia Alves2, Maximiano P Ribeiro3, Massimo Lazzari4, Paula Coutinho5, Ana Otero6.   

Abstract

Exopolysaccharides (EPS) produced by cyanobacteria are complex biomolecules of anionic nature with potential biomedical applications. In this study, the EPS produced by the Nostoc sp. strains PCC7936 and PCC7413 were characterized and evaluated as a biomaterial for new wound dressings. The addition of acetate ions to the culture medium slightly stimulated EPS production, achieving 1463.1 ± 16.0 mgL-1 (PCC7413) and 1372.1 ± 29.0 mgL-1 (PCC7936). Both EPS presented nine monosaccharide residues and a MW > 1000 kDa. The acetate addition changed the monosaccharide molar percentages. FTIR and DLS results confirmed the anionic nature and the presence of sulfate groups in both EPS, which are determinant features for biomedical applications. Both EPS at 1%(w/v) formed gels in the presence of 0.4%(w/v) FeCl3. Results obtained for MTT assay and wound healing in vitro scratch assay revealed hydrogels biocompatibility and ability to promote fibroblast migration and proliferation that was greater in PCC7936. The Nostoc EPS hydrogels presented promising properties to be applied in the treatment of skin injuries.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Exopolysaccharide; Hydrogel; Nostoc sp.; Wound healing

Mesh:

Substances:

Year:  2020        PMID: 33357870     DOI: 10.1016/j.carbpol.2020.117303

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  8 in total

Review 1.  Photosynthetic microorganisms and their bioactive molecules as new product to healing wounds.

Authors:  Alexsandra Frazão de Andrade; Ana Lúcia Figueiredo Porto; Raquel Pedrosa Bezerra
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-05       Impact factor: 4.813

2.  Biopolymer from Water Kefir as a Potential Clean-Label Ingredient for Health Applications: Evaluation of New Properties.

Authors:  Monalisa de Alencar Lucena; Igor Frederico da Silveira Ramos; Maurycyo Silva Geronço; Ricardo de Araújo; Francisco Lopes da Silva Filho; Luís Manuel Lopes Rodrigues da Silva; Rayran Walter Ramos de Sousa; Paulo Michel Pinheiro Ferreira; Josy Anteveli Osajima; Edson Cavalcanti Silva-Filho; Márcia Dos Santos Rizzo; Alessandra Braga Ribeiro; Marcilia Pinheiro da Costa
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

Review 3.  Exopolysaccharides from Microalgae and Cyanobacteria: Diversity of Strains, Production Strategies, and Applications.

Authors:  Céline Laroche
Journal:  Mar Drugs       Date:  2022-05-21       Impact factor: 6.085

Review 4.  Biomedical Applications of Bacterial Exopolysaccharides: A Review.

Authors:  Masrina Mohd Nadzir; Retno Wahyu Nurhayati; Farhana Nazira Idris; Minh Hong Nguyen
Journal:  Polymers (Basel)       Date:  2021-02-10       Impact factor: 4.329

5.  Biocompatibility of the Biopolymer Cyanoflan for Applications in Skin Wound Healing.

Authors:  Raquel Costa; Luís Costa; Ilda Rodrigues; Catarina Meireles; Raquel Soares; Paula Tamagnini; Rita Mota
Journal:  Mar Drugs       Date:  2021-03-11       Impact factor: 5.118

6.  Characterization, antioxidant and anticoagulant properties of exopolysaccharide from marine microalgae.

Authors:  Zahra Mousavian; Maliheh Safavi; Farzaneh Azizmohseni; Mahnaz Hadizadeh; Saeed Mirdamadi
Journal:  AMB Express       Date:  2022-03-03       Impact factor: 3.298

7.  First Report on the Streptococcusgallolyticus (S. bovis Biotype I) DSM 13808 Exopolysaccharide Structure.

Authors:  Anna Maciejewska; Czeslaw Lugowski; Jolanta Lukasiewicz
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

8.  An intrinsically bioactive hydrogel with on-demand drug release behaviors for diabetic wound healing.

Authors:  Bin Hu; Mingzhu Gao; Kofi Oti Boakye-Yiadom; William Ho; Wei Yu; Xiaoyang Xu; Xue-Qing Zhang
Journal:  Bioact Mater       Date:  2021-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.